Home Innovation That Matters

Innovation That Matters

Inside Perspectives: Exscientia’s CEO Predicts AI Will Up the Ante for Drug Hunters

Exscientia, located in Great Britain, is at the forefront of Artificial Intelligence (AI)-driven drug discovery and design. By fusing the power of AI with the discovery experience of seasoned drug hunters, Exscientia is the first company to automate drug design, surpassing conventional approaches. Exscientia’s...

Inside Perspectives: NuMedii Banking on Artificial Intelligence to Expedite the Discovery of Effective New Medicines

One company in the artificial intelligence (AI) space, Menlo Park, Calif.-based NuMedii, has been pioneering the use of big data, AI and systems biology since 2010 to accelerate the discovery of precision therapies to address high unmet medical needs. As a next generation biopharma...

Inside Perspectives: Numerate Aims for Speedier Drug Development with Artificial Intelligence

One of the “hottest” new areas in drug development is the use of artificial intelligence (AI). In the same way that other industries have developed predictive software to make more precise and accurate decisions, many believe that the pharma industry will be particularly attracted to...

Inside Perspectives: Gene Editing Takes Center Stage

Depending on the scientific expert, gene editing is just another sophisticated gene therapy tool in the fight against human diseases or a technological advance so remarkable it has the potential to change the course of human development and that of every other genus and...

Inside Perspectives on Gene Editing: An Interview with MPM Capital’s Mitchell Finer

MPM Capital Managing Director Mitchell H. Finer, Ph.D. – a 30-year gene and cell therapy veteran – describes the relatively new science of gene editing, or genome engineering, as “very exciting.” But he also is quick to add that genome engineering as a marketed...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

Cyclica CEO Naheed Kurji Says AI Could Create a New Paradigm...

Toronto-based Cyclica President and CEO Naheed Kurji acknowledges that artificial intelligence (AI) is a transformative technology, but he contends it is not the “silver...